WT1 is a modifier of the Pax2 mutant phenotype: cooperation and interaction between WT1 and Pax2

Overview of attention for article published in Oncogene, November 2003

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

patent: 19 patents

Readers on

mendeley: 31 Mendeley
citeulike: 2 CiteULike

So far, Altmetric has seen 19 patents that reference this research output.

Targeting PAX2 for the treatment of breast cancer

Grant US-11033628-B1

United States of America

15 Jun 2021

Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy

Grant US-8735365-B2

United States of America

27 May 2014

Detecting PAX2 for the diagnosis of breast cancer

Grant US-8722367-B2

United States of America

13 May 2014

Targeting PAX2 for the treatment of breast cancer

Grant US-8653021-B2

United States of America

18 Feb 2014

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 15 additional patents.